$ARWR news
The latest ARWR stock news: headlines, filings, AI summaries and sentiment for $ARWR, updated around the clock.
- Arrowhead Pharmaceuticals Reports Significant Reduction in Pancreatitis Rates via Plozasiran
- ARROWHEAD PHARMACEUTICALS, INC. - 8-K Filing
- Arrowhead Pharmaceuticals Reports Positive Trial Data for Alzheimer’s Drug
- Arrowhead Pharmaceuticals Director Sells Shares Worth $1 Million
- Arrowhead Pharmaceuticals Director Sells $1 Million Worth of Shares
- Arrowhead Pharmaceuticals' Plozasiran Could Drive Stock Re-rating
- Arrowhead Pharmaceuticals (ARWR) Reaches Five-Year High as Plozasiran Nears sNDA Submission
- Arrowhead Pharmaceuticals Stock Rises on Late-Stage Trial Success
- Arrowhead Reports Positive Late-Stage Trial Results for Lipid Drug, Impacting Rival Ionis Pharmaceuticals
- Arrowhead Reports Key Updates on REDEMPLO and Phase III Trials for Q2 2026 Earnings Call
- ARROWHEAD PHARMACEUTICALS, INC. - 10-Q Filing
- ARROWHEAD PHARMACEUTICALS, INC. - 8-K Filing
- Sarepta Therapeutics Reports Q1 2026 Earnings